(Q42845252)

English

Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease

scientific article published on 28 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Alzheimer's disease

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Moussa B. H. Youdim

3

object named as

Moussa B H Youdim

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

author name string

Hailin Zheng

1

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Mati Fridkin

2

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

publication date

28 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Neurochemical Research

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

2117-2123

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The toxic effects of desferrioxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The therapeutic potential of monoamine oxidase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Pro-Chelator Triggered by Hydrogen Peroxide Inhibits Iron-Promoted Hydroxyl Radical Formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small molecule modulators of copper-induced Abeta aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metals in Alzheimer's and Parkinson's diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Copper, iron and zinc in Alzheimer's disease senile plaques

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic treatment of Alzheimer's disease using metal complexing agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective neurotoxicity of clioquinol on the function of the posterior column nuclei

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug development based on the metals hypothesis of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathways towards and away from Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapeutic targets in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intramuscular desferrioxamine in patients with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative stress and neurotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-target-directed ligands to combat neurodegenerative diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic strategies for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20981484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11064-010-0293-1

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42845252&oldid=2205673438"